Poland Study Finds 3-Year Economic Burden of Recurrent Low Back Pain Among Working-Age Adults

Poland Study Finds 3-Year Economic Burden of Recurrent Low Back Pain Among Working-Age Adults

Introduction: Health economic analysis is one of the solutions to optimize healthcare system management. Low back pain (LBP) appears to be increasing in both incidence and financial burden. According to the new pain definition, pain that recurs for more than 3 months should be classified as chronic.…

Introduction: Health economic analysis is one of the solutions to optimize healthcare system management. Low back pain (LBP) appears to be increasing in both incidence and financial burden. According to the new pain definition, pain that recurs for more than 3 months should be classified as chronic. However, evidence on the prevalence and economic impact of recurrent LBP (rLBP) in the working-age population remains limited. The aim of this study was to estimate the approximate direct costs of the working-age population with rLBP. Additionally, analyze the cost-per-visit across different age groups and types of medical services. A bottom-up framework was used to estimate the national burden of rLBP in Poland, based on data from the Polish National Health Fund and representative hospital records from 2019 to 2021. The analysis included individuals aged 21–65 years with LBP-related ICD-10 diagnoses. Retrospective observational study. The mean annual direct cost of working-age LBP individuals in Poland was €184,986,519 including €13,699,529 from rLBP (95% CI: €9,829,766–17,522,323). 24.51% of LBP cases were classified as rLBP, covering 54.28% of medical services and 38.37% total LBP costs. The median cost-per-visit for rLBP was significantly higher compared to non-rLBP overall and specific age subgroups (p < 0.001). rLBP accounted for 34.72% of total LBP costs in individuals aged over 35 years (over 50 years 23.65%), including 21.56% (over 50 years 14.43%) for inpatient admissions and 10.79% (over 50 years 7.69%) for physiotherapy. Using the bottom-up framework, the estimated cost of rLBP in Poland was €13,699,529, representing 24.51% of cases in representative hospital data. rLBP showed higher per visit costs than overall LBP across all age groups. Patients over 35 years old accounted for 34.72% of total LBP expenses and two-fifths of all medical services. Moreover, outpatient visits to physiotherapy services were predominant.

Frontiers | Economic burden of recurrent low back pain among working-age adults in Poland: a 3-year retrospective observational analysis

argue that as aggregated cost data increase (for example, at the population level), the weaker the relationship between expenditure and actual health outcomes becomes (7). Consequently, analyses conducted at the individual level, such as cost-per-visit assessments, more accurately capture the true variability of service costs (7). Although the per-visit approach is not the dominant standard, it is considered highly useful when evaluating the efficiency of a specific service, identifying inefficiencies, or determining unit costs for use in more advanced economic models (8–11).

A pertinent example of the value of economic analysis in the context of implementing ICD-11 within national health systems is the newly introduced entry "Chronic Pain" (MG.30). Its adoption requires separate diagnostic and therapeutic pathways, each with its own ICD-11 code, for a condition that was previously diagnosed with a single code.

Some chronic diseases, such as low back pain (LBP), appear to be on the rise, both in terms of the occurrence and economic impact (18–21). Evidence indicates that among working-age individuals, LBP can lead to decreased productivity (22–24), increased absenteeism (25–27), and premature retirement (28). These issues are particularly notable among people aged 35–55 years (19, 29–31) and women (11, 32, 33).

Alarmingly, the prevalence of chronic low back pain (cLBP) has doubled over the past decade (34). Thus, we can expect an increasing burden on national healthcare systems and the economy due to LBP (30, 35–37), including its chronic state (38–41).

According to the European Union Survey on the Living Conditions of the Population, work incapacity affects 20–60% of Poland's working-age population, depending on age (42).

Frontiers | Economic burden of recurrent low back pain among working-age adults in Poland: a 3-year retrospective observational analysis

EUROSTAT data further indicate that nearly one in four working adults in Poland suffers from at least two chronic diseases, with cLBP being one of them (1). Based on the new IASP definition of chronic pain (16), our recent study offered the first accurate estimate of the direct medical costs of recurrent LBP (rLBP) using a cost-per-visit approach. This confirmed the higher costs of rLBP and revealed cost differences associated with sex and the type of health service utilized. Additionally, modelling the annual costs for Poland (approximately €243.9 million per year) emphasized the substantial economic burden of rLBP. This information may support more efficient resource distribution and evidence-based health policy planning (11). There is limited evidence in the current literature on the prevalence of rLBP (3) and its associated economic burden (33, 43). A study from Japan estimated the annual total medical costs for patients with cLBP at €12,551 (43). Meanwhile, a 2023 meta-analysis indicated that, in high-income countries, the average annual direct costs associated with LBP amount to approximately $9,000 per patient, posing a significant burden on healthcare systems and national economies (37). In light of ICD-11-based chronic pain management (44), and the high prevalence of LBP chronicity with age, it is vital to determine the cost differences based on age ranges (3, 5, 21) and the medical services provided by multidisciplinary teams (45–48). In this study, rLBP is approached as a specific pattern of healthcare utilization associated with chronic pain, rather than as a diagnosis defined exclusively by symptom duration. By focusing on repeated episodes that require ongoing medical attention, this approach enables the identification of cost drivers related to service type and patient age, which may remain obscured in aggregated cost analyses. In the context of the ICD-11 classification of chronic pain, such an economic perspective aligns with the emphasis on care pathways and multidisciplinary management, offering insights relevant to the optimization of healthcare resource allocation. Therefore, based on a three-year retrospective observational study, we aimed to estimate the costs incurred by the working-age population with rLBP. Additionally, we examined differences in cost-per-visit across age groups and types of medical services.

Frontiers | Economic burden of recurrent low back pain among working-age adults in Poland: a 3-year retrospective observational analysis

Based on this determination, patient consent was deemed unnecessary, as the study did not involve experimental procedures or the processing of personal data. This study was reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines (49).

2.1 Data sources Data on the volume of medical services and total treatment expenditures for working-age patients with LBP in Poland were obtained from the Polish National Health Fund (NHF) for the years 2019–2021. The dataset was classified using ICD-10 codes G54, G55, M45, M46, M47, M48, M49, M51, M53, and M54, and included patients' age and the monetary value of services associated with these diagnoses.

2.2 Study sample and data analysis We assessed the total costs of LBP-related medical services provided to working-age adults at OCR during the 2019–2021 observation period, categorized by ICD-10 codes and recurrent status, as outlined in the new chronic pain definition (17, 50). Regarding the definition of rLBP (51), it underscores the difficulty of adopting a single, uniform definition for this condition (50). However, based on the work of de Vet (52), rLBP can be defined as episodes of LBP occurring after periods without symptoms or after periods during which the patient has not sought medical care for LBP (53). De Vet also recommends a minimum 30-day interval between symptom resolution and recurrence. Since chronic pain is defined as lasting longer than 12 weeks and patients may not seek care immediately after symptoms resolve, a 30-day pain-free interval was adopted as the operational threshold (52). Although a 30-day pain-free interval is commonly used in clinical definitions of recurrent LBP, applying this threshold in administrative healthcare datasets is challenging, as symptom resolution and pain-free periods are not directly observable. Therefore, to minimize the risk of misclassifying ongoing treatment episodes as true recurrences and to better reflect real-world healthcare utilization patterns, a six-month interval between recorded medical encounters under the same ICD-10 code was adopted as the operational definition of recurrence.

Frontiers | Economic burden of recurrent low back pain among working-age adults in Poland: a 3-year retrospective observational analysis

Recognizing that patients frequently postpone seeking medical attention after symptom recurrence, and aiming to align with real-world healthcare utilization patterns, we defined rLBP in our dataset as any subsequent medical service recorded under the same ICD-10 code occurring at least 6 months after the initial encounter. This operational definition was intended to capture clinically meaningful recurrence as reflected in routine medical records. Based on this criterion, patients were subsequently categorized according to the number of revisits occurring no earlier than 6 months after the original LBP diagnosis. Individuals were assigned to either the non-recurrent or recurrent LBP group, with recurrent LBP defined as having three or more return visits for the same diagnostic category.

Additionally, analyses were stratified by age group—G1 (21–35 years), G2 (36–50 years), and G3 (51–65 years)—and by type of medical service received, including inpatient admissions (orthopedics and rehabilitation wards), outpatient consultations, and physiotherapy services. It should be noted that patients could use more than one type of service (inpatient, outpatient, or physiotherapy). When reporting the distribution of service types utilized by patients, the total percentage may exceed 100%. Excluding patients with mixed or non-recurrent patterns may overlook individuals who experience intermittent or infrequent episodes of LBP, potentially underestimating the overall burden of low back pain across diverse patient groups. This limitation may also reduce the generalizability of the findings to the broader LBP population.

Moreover, applying a 6-month interval between medical encounters may omit patients who seek care within shorter time frames, and the interchangeable use of various ICD-10 codes for similar clinical presentations may result in incomplete case identification. Nonetheless, the exclusion criteria were implemented to create a more homogeneous cohort for the analysis of recurrent LBP, and we consider the resulting bias minimal given the study design.

The analysis was informed by OCR records, which provided age-specific frequencies of medical services delivered to patients with rLBP. These frequencies were used to project the expected number of corresponding services performed nationally between 2019 and 2021. To assign monetary values to individual procedures, NHF reimbursement tariffs were applied to each OCR service.

Frontiers | Economic burden of recurrent low back pain among working-age adults in Poland: a 3-year retrospective observational analysis

The mean cost per service, along with its 95% confidence interval (95% CI), was estimated using a bootstrap method in which 5,000 resamples were generated, with each service having a 50% probability of selection in each iteration. The projected national cost of rLBP was calculated by multiplying the estimated number of services in Poland by the mean OCR service value. This method provided an age-stratified estimate of the overall financial burden attributable to rLBP. To derive the annual cost, the three-year cumulative estimate was divided by three.

According to NHF records from 2019 to 2021, the mean annual direct expenditure on medical care for working-age individuals with LBP in Poland was €184,986,519, with an average of 218,214 services delivered annually. When stratified by age, the mean yearly number of services was 53,942 in G1, 79,052 in G2, and 85,220 in G3.

An analysis of the OCR dataset from 2019 to 2021 allowed us to derive age-group-specific estimates of the unit cost for rLBP–related procedures, which were subsequently extrapolated to national figures.

Frontiers | Economic burden of recurrent low back pain among working-age adults in Poland: a 3-year retrospective observational analysis

When these group-level cost estimates were applied to the corresponding number of procedures performed in Poland, the combined annual financial burden attributable to rLBP was calculated at €13,699,529, with a 95% confidence interval of €9,829,766 to €17,522,323. Each age group contributed differently to the overall expenditure. For G1, the annual cost associated with recurrent LBP was estimated at €2,900,163 (95% CI: € 1,569,901 - €4,216,081). In G2, the projected annual expenditure was €4,499,310, with an uncertainty interval from €3,233,881 to €5,763,650. The highest cost was observed in G3, with an annual estimate of €6,300,056 (95% CI: €5,025,984 - €7,542,592).

The mean annual direct cost of LBP-related services was €285,765, corresponding to 1,699 procedures. In the working-age LBP cohort, we observed a statistically significant exponential increase in the proportion of patients with advancing age (p < 0.001), with age-group distributions of 11.85% in G1, 34.25% in G2, and 53.9% in G3 (p < 0.000001). A similar pattern was evident in the utilization of medical services: the total number of services increased progressively across age groups, with G1 accounting for 11.07%, G2 for 34.44%, and G3 for 54.49% of all services. Throughout the entire LBP population, the number of medical encounters, total expenditures, and cost-per-visit increased with age, with patients aged 50 years and older (G3) exhibiting the highest resource use (Table 1).

The distribution of specific medical services also varied by age. Among all LBP cases, inpatient admissions accounted for 7.88% of services in G1, 30.98% in G2, and 61.14% in G3. Physiotherapy services represented 9.79, 31.23, and 58.98% across the same groups, whereas outpatient consultations accounted for 14.96, 36.48, and 48.56%, respectively.

The highest median cost-per-visit in the OCR cohort was associated with inpatient admissions. A detailed summary of median per-visit costs, total costs, and the number of services across age groups is presented in Table 1.

The rLBP group represented 24.51% of all working-age LBP patients, 54.28% of all LBP medical services, and 38.37% of total LBP costs. The proportion of patients in the rLBP group increased with age, accounting for 2.35% in G1, 7.86% in G2, and 14.30% in G3, and was significantly lower (p < 0.001) compared to the non-rLBP group, which had shares of 9.50% in G1, 26.38% in G2, and 39.61% in G3.

A similar trend was observed in the number of medical services, with the rLBP group accounting for 4.79% in G1, 18.01% in G2, and 23.40% in G3, whereas the non-rLBP group accounted for 6.28% in G1, 16.43% in G2, and 32.40% in G3.

The analysis revealed that the median cost-per-visit for rLBP was significantly higher compared to non-rLBP (p < 0.001) overall and in specific age subgroups (p < 0.001). In rLBP, the cost-per-visit remained high across all age groups, whereas in non-rLBP it increased gradually with age, aligning with the overall LBP trend.

Despite constituting a minority of the overall working-age LBP population, patients with recurrent LBP accounted for a disproportionately large share of healthcare utilization and direct medical costs. Notably, in rLBP, patients aged 35 and older (G2, G3) accounted for 22.16% of all LBP cases, 34.72% of costs, and 41.41% of services.

The analysis of the distribution of medical services by patients' recurrence status showed that, in inpatient admissions, the rate of rLBP was 3.71%, compared with 13.59% for non-rLBP. In outpatient care, it was 23.04% for rLBP versus 42.34% for non-rLBP.

Frontiers | Economic burden of recurrent low back pain among working-age adults in Poland: a 3-year retrospective observational analysis

For physiotherapy services, the rates were 15.71% for rLBP and 27.51% for non-rLBP. A detailed data analysis of rLBP versus non-rLBP by age subgroups was as follows: G1: inpatients 0.47% vs. 0.89%, outpatients 2.30% vs. 7.48%, physiotherapy services 1.60% vs. 2.63%; G2: inpatients 1.08% vs. 4.28%, outpatients 7.43% vs. 16.42%, physiotherapy services 4.94% vs. 8.56%; and G3: inpatients 2.16% vs. 8.42%, outpatients 13.31% vs. 18.44%, physiotherapy services 9.17% vs. 16.32%. Patients aged 35 years or older (G2 + G3) in the non-rLBP subgroup accounted for 56.15% of total costs across the LBP population, including 36.52% for inpatient admissions and 19.63% for physiotherapy. The second-highest cost was incurred by patients aged 35 years and older in the rLBP subgroup, accounting for 34.72% of all costs, including 21.56% for inpatient admissions and 10.78% for physiotherapy (Table 3). The analysis of cost-per-visit indicates a statistically significant higher treatment cost for rLBP compared to non-rLBP in outpatient admissions across all age groups, as well as in inpatient admissions for patients over 35 years of age (G2 and G3). Furthermore, an exponential increase in physiotherapy costs with age was observed in both the rLBP and non-rLBP groups. Additionally, an age-related increase in total treatment costs was observed only in the rLBP group, whereas inpatient treatment costs decreased with age among patients with rLBP. Detailed data, divided by age groups, is presented in Table 3.

The annual direct cost attributable to rLBP was estimated at €13,699,529, representing approximately 7.4% of the overall direct expenditures for LBP.

Our findings indicated that the highest treatment costs among working-age individuals with LBP were observed in those over 50 years old. Care for this group accounted for more than half of total direct costs and involved more than 50% of all healthcare services provided. Patients with rLBP comprised nearly a quarter of the overall LBP population. Within this subgroup, individuals aged 50 and older were responsible for 23.65% of all direct LBP-related costs and received one-fourth of all LBP-related healthcare services. The substantial cost of treating rLBP, regardless of age, is further supported by the per-visit analysis, which highlights the significant role of inpatient and physiotherapy care in driving overall costs (Tables 2, 3). We found that one-quarter of all working-age individuals with LBP were classified as having recurrent episodes. Notably, this subgroup accounted for nearly 40% of total direct healthcare costs, driven primarily by their use of more than half of the provided health services, particularly inpatient care and physiotherapy. Both the size of the working-age rLBP population and the direct costs associated with their management clearly highlight the need to treat this subgroup as a distinct clinical category.

Frontiers | Economic burden of recurrent low back pain among working-age adults in Poland: a 3-year retrospective observational analysis

This issue becomes even more relevant with the implementation of the MG.30 category within ICD-11 (12, 13), as the introduction of this new diagnostic unit necessitates system-level adjustments to healthcare service allocation. In line with WHO recommendations, the management of conditions classified as chronic primary pain (MG30.0) is expected to rely more heavily on physiotherapy, often combined with cognitive-behavioral therapy (66, 67). The cost-per-visit framework proposed in our study — an approach seldom applied in previous health-economic analyses — serves as a valuable tool for evaluating treatment expenditures and guiding the restructuring of service delivery in line with ICD-11 recommendations (41). Prior research has demonstrated considerable variability in the distribution of direct healthcare costs among LBP populations, with recurrent or high-utilization subgroups accounting for a disproportionate share of expenditures (55, 68). In our analysis, we found that patients with rLBP incurred significantly higher per-visit costs than those without rLBP, and these elevated costs remained consistently high across all age groups (Table 2). Similarly, for cLBP, substantially higher unit costs per patient and per visit were observed compared to acute or non-specific LBP (40, 69). The difference was especially evident in subgroups with a neuropathic component (65). A more detailed review of age-related service utilization patterns further suggests that the traditional focus on individuals aged 50 and older may be insufficient for rLBP, as increased costs were evident from age 35 onward. Notably, patients aged 35 and older in the rLBP subgroup accounted for nearly one-third of total expenditures, including approximately one-fifth attributable to inpatient admissions and just over 10% to physiotherapy (Table 3). Chronic LBP is associated with significantly higher hospital treatment costs than acute LBP. Limiting the analysis to those over 50 increases this disparity, as older patients are more likely to experience chronic pain, requiring more intensive and costly inpatient stays and specialist procedures. Other researchers have also confirmed that direct expenses vary significantly depending on the type of service, with hospital admissions incurring higher costs than outpatient care or physiotherapy services (70, 71). Therefore, despite the low proportion of cLBP patients using this type of treatment, optimizing it in line with the latest advances in pain medicine will be a key step in reducing future direct costs. Accordingly, our findings support prior literature indicating that a per-visit analytical approach facilitates the identification of medical service types that are cost-intensive or potentially inefficient. Cost-per-visit constitutes a key parameter for improving the efficiency of healthcare resource allocation across different service areas.

Frontiers | Economic burden of recurrent low back pain among working-age adults in Poland: a 3-year retrospective observational analysis

We propose that the median cost-per-visit provides a more stable and informative measure of the relationships between cost and the factors examined. This metric is particularly relevant in chronic pain management, where the biopsychosocial framework underscores the importance of coordinated, multidisciplinary interventions that collectively improve therapeutic outcomes (44, 45, 72). In the context of chronic pain (ICD-11: MG.30), there is a growing emphasis on reorganizing health service management by structuring care for cLBP around four key clinical professions: physicians, nurses, physical therapists, and psychologists (73–75). At the same time, there is widespread emphasis on aligning diagnostic and therapeutic practices with the latest WHO recommendations, which highlight the importance of a biopsychosocial approach to the treatment of chronic pain (76, 77). Furthermore, long-standing scientific evidence indicating that routine imaging should not be a standard diagnostic procedure for chronic musculoskeletal disorders, including nonspecific low back pain, strengthens the case for evidence-based services (78, 79).

In summary, these findings support the view that combining clinical guidelines with economic analyses provides a solid foundation for rational and sustainable healthcare system reforms (80, 81). In the absence of effective therapeutic options, patients with rLBP often make repeated attempts to seek care, including additional diagnostic evaluations and pharmacological interventions. Our study confirmed that only 15.71% of these patients use physiotherapy. Importantly, this low utilization occurs despite physiotherapy contributing to higher per-visit cost estimates, indicating that its role in cost generation reflects higher unit prices rather than overuse.

The relatively small proportion of physiotherapy services within the rLBP group suggests a potential mismatch between current service usage patterns and evidence-based guidelines for chronic pain management. This raises the question of whether the high volume of services provided to patients with rLBP in outpatient settings, accounting for approximately 23% of all visits for LBP, and the higher cost-per-visit compared to patients with non-rLBP, should be partly shifted towards primary care, especially toward physiotherapy. Other authors have estimated that physiotherapy accounts for 20–32% of direct healthcare costs to date (82). Furthermore, despite increasing total expenditure per patient, a series of physiotherapy visits significantly improves treatment effectiveness, reducing costs by limiting the need for more expensive services, such as hospital admission or pharmacological treatment (82). Similar concerns regarding inefficient allocation of resources in LBP pathways have been raised in recent health services research (81, 83).

Frontiers | Economic burden of recurrent low back pain among working-age adults in Poland: a 3-year retrospective observational analysis

It can further be assumed that patients reporting recurrent pain symptoms, experienced for example over 2 weeks, are commonly referred by primary care physicians for additional specialist diagnostics. However, in light of current evidence and the classification of rLBP as a form of chronic pain, such referral patterns seem inconsistent with contemporary clinical recommendations (76, 77, 83). Current models of chronic pain management emphasize differentiating diagnostic and therapeutic approaches according to the predominant phenotype perpetuating pain, with clinical assessment primarily guided by physical examination and standardized self-report questionnaires (16). Conversely, routine use of imaging, such as MRI or ultrasound, or laboratory tests is recommended only when a differential diagnosis is required, or red-flag symptoms are present (84, 85).

The expense of treating this subgroup represents nearly a quarter (25%) of all LBP costs, with almost 15% attributable to patients aged 50 years and older. This prompts inquiry into the potential influence of this particular group on the development of the phenomenon known as post-surgical low back pain syndrome (PSLBP), also known as failed back surgery syndrome (FBSS), which affects up to 40% of patients (86, 87). It is plausible that, in a subset of patients, persistent pain results from central sensitization processes that do not respond to interventional treatments, necessitating multimodal therapy that excludes invasive methods. The literature suggests that up to 30% of LBP cases may exhibit features of central sensitization in pain persistence (88).

The treatment approach for chronic pain recommended by the WHO and EFIC, which acknowledges the vital role of physiotherapy combined with cognitive-behavioral therapy (CBT) (47, 77), should perhaps precede surgical procedures, especially in the rLBP group aged 50 and over (Table 3). From a clinical perspective, 90% of LBP cases are classified as non-specific pain, meaning that in chronic and especially recurrent states, this remains the predominant patient group. For this group, the WHO does not recommend pharmacotherapy beyond NSAIDs, but instead highlights the important role of modern physiotherapy in collaboration with a psychologist specializing in chronic pain (76, 89).

Consequently, implementing these recommendations in national healthcare systems is hypothesized not only to improve treatment efficacy but also to significantly reduce treatment costs, as corroborated by our analyses using per-visit metrics and overall rLBP expenditure. A key finding of our study, in the context of the proposed changes to ICD-11, is the disproportionately low utilization of physiotherapy services among the working-age LBP population.

Frontiers | Economic burden of recurrent low back pain among working-age adults in Poland: a 3-year retrospective observational analysis

The overall usefulness of the results is based on identifying significant costs of rLBP treatment and analyzing per-visit costs, considering the type of medical service. These data appear to have a utilitarian nature, which should be considered. Current medical recommendations for MG. Thirty favor allocating outpatient services to outpatient physiotherapy, particularly for patients with chronic primary LBP. However, the results of the cost simulation for the whole country should be approached with caution.

Analyses of both total healthcare expenditures and per-visit costs consistently demonstrate that the highest treatment expenses are incurred in this age cohort. This segment represents more than half of the total LBP population, accounts for approximately half of all treatment costs, and utilizes roughly half of all medical services and benefits.

4.1 Future perspective Considering the substantial financial burden associated with rLBP, prioritizing interventions specifically designed for this subgroup could improve clinical outcomes and reduce overall healthcare expenditure. Consequently, future research should explore the long-term impacts and cost-effectiveness of different treatment modalities for cLBP, including analyses at the per-visit level.

4.2 Limitations Several factors limit the findings of this study. Primarily, there is a deficiency of data pertaining to the costs associated with primary healthcare and consultations. Additionally, data from departments favoring surgical procedures are missing. Furthermore, the analysis of inpatient admissions should differentiate between invasive and non-invasive therapeutic procedures.

The selection of the study population necessitates precise diagnostic coding for each diagnosis associated with specific treatments or provider visits. Also, due to the retrospective nature of the study, limitations include the absence of data on comorbidities, income levels, healthcare access, work disability, and related indirect costs. Furthermore, in Poland, healthcare services are primarily financed by the National Health Fund. Future research should consider variables such as national healthcare policies, income levels, and access to private healthcare.

The period during which the study was conducted coincided with the COVID-19 pandemic, which may have affected the results.

Since this study does not analyze epidemiological data but instead explores the impact of rLBP on economic assessments, it is advisable for future studies to cover a 10-year period to facilitate additional observations.

Using the bottom-up framework, the estimated cost of rLBP in Poland was €13,699,529, representing 24.51% of cases in representative hospital data. rLBP showed higher per-visit costs than overall LBP across all age groups. Patients over 35 years old accounted for 34.72% of total LBP expenses and two-fifths of all medical services. Moreover, outpatient visits to physiotherapy services were predominant. Future health economic research should prioritize the assessment of the justification for surgical interventions in cases of rLBP.

Nothing. The passage appears to be a list of references and citations related to the topic of low back pain, but it does not contain any article text that belongs to the headline "Frontiers | Economic burden of recurrent low back pain among working-age adults in Poland: a 3-year retrospective observational analysis".

After applying the text-cleaning rules, I am left with:

The passage appears to be a list of references or citations related to low back pain, but it does not contain any article text that belongs to the headline "Frontiers | Economic burden of recurrent low back pain among working-age adults in Poland: a 3-year retrospective observational analysis".

Frontiers | Economic burden of recurrent low back pain among working-age adults in Poland: a 3-year retrospective observational analysis

Szyszka J, Matuska J, Szyszka B, Walkowiak D and Skorupska E (2026) Economic burden of recurrent low back pain among working-age adults in Poland: a 3-year retrospective observational analysis. Front. Public Health 14:1805628. doi: 10.3389/fpubh.2026.1805628

Reported from Frontiers

Related articles